Dexmedetomidine

interleukin 1 beta ; Mus musculus







11 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34782991 Tailored Therapeutic Doses of Dexmedetomidine in Evolving Neuroinflammation after Traumatic Brain Injury. 2022 Jun 1
2 33821300 Dexmedetomidine ameliorates lipopolysaccharide-induced acute lung injury by inhibiting the PI3K/Akt/FoxO1 signaling pathway. 2021 Jun 1
3 34747306 Protective effect of dexmedetomidine in cecal ligation perforation-induced acute lung injury through HMGB1/RAGE pathway regulation and pyroptosis activation. 2021 Dec 1
4 29269298 Dexmedetomidine attenuates pancreatic injury and inflammatory response in mice with pancreatitis by possible reduction of NLRP3 activation and up-regulation of NET expression. 2018 Jan 22 3
5 30071186 The effect of dexmedetomidine on inflammatory inhibition and microglial polarization in BV-2 cells. 2018 Oct 2
6 28224201 Dexmedetomidine protects against cisplatin-induced acute kidney injury in mice through regulating apoptosis and inflammation. 2017 May 1
7 28784305 Dexmedetomidine (DEX) protects against hepatic ischemia/reperfusion (I/R) injury by suppressing inflammation and oxidative stress in NLRC5 deficient mice. 2017 Nov 18 1
8 26211495 Dexmedetomidine attenuates acute lung injury induced by lipopolysaccharide in mouse through inhibition of MAPK pathway. 2015 Oct 1
9 26702389 The role of spleen in the treatment of experimental lipopolysaccharide-induced sepsis with dexmedetomidine. 2015 1
10 24803295 Dexmedetomidine controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. 2014 Oct 1
11 19181340 Effects of dexmedetomidine on regulating endotoxin-induced up-regulation of inflammatory molecules in murine macrophages. 2009 Jun 15 1